Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Molecular analysis of breast cancers: recent developments].

I Bièche¹, R Lidereau

¹Laboratoire d'oncovirologie, centre René-Huguenin, Saint-Cloud, France.

Bulletin Du Cancer

|January 1, 1992

Summary

Genetic alterations like gene amplification and mutations are key in breast cancer development. Identifying these genetic changes aids in earlier diagnosis and understanding cancer predisposition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The impact of targeted therapies on molecular alterations identified by an institutional molecular tumor board: an approach based on ESCAT classification.

ESMO real world data and digital oncology·2026

Same author

HPV circulating tumor DNA to monitor response to pembrolizumab and vorinostat combination in patients with advanced HPV-related squamous-cell carcinomas.

ESMO open·2025

Same author

Corrigendum to "Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group": [Ann Oncol 35 (2024) 588-606].

Annals of oncology : official journal of the European Society for Medical Oncology·2025

Same author

Paving the path towards tissue-agnostic drug approval in oncology.

Annals of oncology : official journal of the European Society for Medical Oncology·2024

Same author

Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group.

Annals of oncology : official journal of the European Society for Medical Oncology·2024

Same author

Tumor <i>BRCA</i> testing can reveal a high tumor mutational burden related to <i>POLE</i> pathogenic variants.

Gynecologic oncology reports·2021

Area of Science:

Oncology
Genetics
Molecular Biology

Context:

Cancer etiology involves complex genetic alterations.
Tumorigenesis is characterized by specific genetic mutations and chromosomal abnormalities.
Human breast cancer exhibits frequent genetic changes, including proto-oncogene amplification and tumor-suppressor gene inactivation.

Purpose:

To identify and characterize common genetic alterations in human breast cancer.
To understand the role of genetic deletions and mutations in inactivating tumor-suppressor genes.
To map breast cancer susceptibility genes using linkage analyses in high-risk families.

Summary:

Major genetic abnormalities in breast cancer include amplification of proto-oncogenes (c-myc, c-erbB-2/neu) and chromosome 11q13, p53 mutations, and loss of heterozygosity at various chromosomal locations.
These genetic alterations can lead to the inactivation of tumor-suppressor genes.
Linkage analyses are identifying genes associated with hereditary breast cancer, emphasizing the need for early diagnosis in high-risk individuals.

Impact:

Understanding these genetic alterations can inform diagnostic strategies and risk assessment for breast cancer.
Identification of susceptibility genes aids in genetic counseling and targeted screening for hereditary breast cancer.
Early diagnosis through surveying high-risk patients can improve patient outcomes.

Related Experiment Videos